FDANonrulemakingFDA-2022-D-1837
Who commented on this docket
Statement of Identity and Strength — Content and Format of Labeling for Human Nonprescription Drug Products
1 organizations filed 1 public comment on Statement of Identity and Strength — Content and Format of Labeling for Human Nonprescription Drug Products, at the Food and Drug Administration. The comment window closed 1358d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 1358d ago
Abstract
Open
Commenters (1)
- Consumer Healthcare Products Associationtrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.